Glutathione-cholesterol derivatives as brain targeting agents
AssigneeSouth Dakota Board of Regents
InventorsXiangming Guan, Asidim Najmi, Shenggang Wang, Yue Huang, Teresa Seefeldt, Yahya Alqahtani
Life of this patent
Estimating the term…
Abstract
The present invention describes compositions containing cholesterol-linker-glutathione conjugates for targeting the brain by overcoming barrier entry to the CNS through the blood brain barrier (BBB), including micelle and liposome forms of such compositions. In addition, methods for treating subjects by administering such compositions are also disclosed.
Claims20
A blood brain barrier permeable composition, wherein the composition comprises a molecule as set forth in Formula (I), (II), (III), (IV), (V), (VI), (VII), or (VIII):
- wherein R1=OH, O-alkyl (1 to 30 C), O-aryl (6-30 C), O-aryl and O-alkyl combinations (6-30 C), S-alkyl (1-30 C), S-aryl (6-30 C), S-aryl and S-alkyl combinations (6-30 C), N-alkyl (1-30 C), N-aryl (6-30 C), or N-aryl and N-alkyl combinations (6-30 C), combinations thereof;
- R2=OH, O-alkyl (1-30 C), O-aryl (6-30 C), O-aryl and O-alkyl combinations (6-30 C), S-alkyl (1-30 C), S-aryl (6-30 C), S-aryl and S-alkyl combinations (6-30 C), N-alkyl (1-30 C), N-aryl (6-30 C), or N-aryl and N-alkyl combinations (6-30 C), and combinations thereof;
- R3=H, alkyl (1-30 C), aryl (6-30 C), or aryl and alkyl combinations (6-30 C);
- R4=H, alkyl (1-30 C), aryl (6-30 C), or aryl and alkyl combinations (6-30 C), and
- the linker includes alkyl, aliphatic chain, alkoxy and combinations thereof, wherein the composition does not fluoresce in the absence of an exogenous fluorescing compound.
A blood brain barrier permeable composition, wherein the composition comprises a molecule as set forth in formula (I), (II), (III), (IV), (V), (VI), (VII), or (VIII):
- wherein R1=R2=OH, O-alkyl (1-30 C), O-aryl (6-30 C), O-aryl and O-alkyl combinations (6-30 C), S-alkyl (1-30 C), S-aryl (6-30 C), S-aryl and S-alkyl combinations (6-30 C), N-alkyl (1-30 C), N-aryl (6-30 C), or N-aryl and N-alkyl combinations (6-30 C), and combinations thereof;
- wherein R3=R4=H, alkyl (1-30 C), aryl (6-30 C), or aryl and alkyl combinations (6-30 C), and
- the linker includes alkyl, aliphatic chain, alkoxy and combinations thereof, wherein the composition forms micelles.
A kit comprising:
- a) a blood brain barrier permeable composition, wherein the composition comprises a molecule as set forth in:
- (i) formula (I), (II), (III), (IV), (V), (VI), (VII), or (VIII):
- wherein R1=OH, O-alkyl (1 to 30 C), O-aryl (6-30 C), O-aryl and O-alkyl combinations (6-30 C), S-alkyl (1-30 C), S-aryl (6-30 C), S-aryl and S-alkyl combinations (6-30 C), N-alkyl (1-30 C), N-aryl (6-30 C), or N-aryl and N-alkyl combinations (6-30 C), combinations thereof;
- R2=OH, O-alkyl (1-30 C), O-aryl (6-30 C), O-aryl and O-alkyl combinations (6-30 C), S-alkyl (1-30 C), S-aryl (6-30 C), S-aryl and S-alkyl combinations (6-30 C), N-alkyl (1-30 C), N-aryl (6-30 C), or N-aryl and N-alkyl combinations (6-30 C), and combinations thereof;
- R3=H, alkyl (1-30 C), aryl (6-30 C), or aryl and alkyl combinations (6-30 C),
- R4=H, alkyl (1-30 C), aryl (6-30 C), or aryl and alkyl combinations (6-30 C), and
- the linker includes alkyl, aliphatic chain, alkoxy and combinations thereof, wherein the composition does not fluoresce in the absence of an exogenous fluorescing compound or
- (ii) a blood brain barrier permeable composition, wherein the composition comprises a molecule as set forth in formula (I), (II), (III), (IV), (V), (VI), (VII), or (VIII):
- wherein R1=R2=OH, O-alkyl (1-30 C), O-aryl (6-30 C), O-aryl and O-alkyl combinations (6-30 C), S-alkyl (1-30 C), S-aryl (6-30 C), S-aryl and S-alkyl combinations (6-30 C), N-alkyl (1-30 C), N-aryl (6-30 C), or N-aryl and N-alkyl combinations (6-30 C), and combinations thereof;
- wherein R3=R4=H, alkyl (1-30 C), aryl (6-30 C), or aryl and alkyl combinations (6-30 C), and
- the linker includes alkyl, aliphatic chain, alkoxy and combinations thereof, wherein the composition forms micelles;
- b) optionally, one or more compounds selected from phospholipids, cholesterol or buffers;
- c) one or more agents selected from the group consisting of buffers, dyes, fluorescent agents, drugs, chemotherapeutics, nutraceuticals, vitamins, nucleic acids, proteins, antigens, antibodies buffer, a hydrophobic agent, a therapeutic agent, an antioxidant, an anti-inflammatory drug, an anticancer drug, a cosmetic, a pharmaceutical, a pesticide, an insecticide, an herbicide, an antiseptic, a diagnostic agent, a food additive, a fragrance, and a textile and combinations thereof;
- d) instructions reciting a method for producing a composition comprising a liposome or micelle and said one or more agents;
- e) a label;
- and
- f) a container comprising components (a)-(e).
Dependencies are inferred from the claim text.